Protein arginine methyltransferases: promising targets for cancer therapy

JW Hwang, Y Cho, GU Bae, SN Kim… - Experimental & molecular …, 2021 - nature.com
Protein methylation, a post-translational modification (PTM), is observed in a wide variety of
cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic …

The regulation, functions and clinical relevance of arginine methylation

E Guccione, S Richard - Nature reviews Molecular cell biology, 2019 - nature.com
Methylation of arginine residues by protein arginine methyltransferases (PRMTs) is involved
in the regulation of fundamental cellular processes, including transcription, RNA processing …

Anti-tumor activity of the type I PRMT inhibitor, GSK3368715, synergizes with PRMT5 inhibition through MTAP loss

A Fedoriw, SR Rajapurkar, S O'Brien, SV Gerhart… - Cancer cell, 2019 - cell.com
Type I protein arginine methyltransferases (PRMTs) catalyze asymmetric dimethylation of
arginines on proteins. Type I PRMTs and their substrates have been implicated in human …

[HTML][HTML] RUNX transcription factors: orchestrators of development

R Mevel, JE Draper, M Lie-a-Ling, V Kouskoff… - …, 2019 - journals.biologists.com
ABSTRACT RUNX transcription factors orchestrate many different aspects of biology,
including basic cellular and developmental processes, stem cell biology and tumorigenesis …

The RUNX family: developmental regulators in cancer

Y Ito, SC Bae, LSH Chuang - Nature Reviews Cancer, 2015 - nature.com
RUNX proteins belong to a family of metazoan transcription factors that serve as master
regulators of development. They are frequently deregulated in human cancers, indicating a …

Protein arginine methylation in mammals: who, what, and why

MT Bedford, SG Clarke - Molecular cell, 2009 - cell.com
The covalent marking of proteins by methyl group addition to arginine residues can promote
their recognition by binding partners or can modulate their biological activity. A small family …

[HTML][HTML] Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance

Y Zhu, T **a, DQ Chen, X **ong, L Shi, Y Zuo… - Drug Resistance …, 2024 - Elsevier
Drug resistance remains a major challenge in cancer treatment, necessitating the
development of novel strategies to overcome it. Protein arginine methyltransferases …

Regulation of transcription factor activity by interconnected post-translational modifications

TM Filtz, WK Vogel, M Leid - Trends in pharmacological sciences, 2014 - cell.com
Transcription factors comprise just over 7% of the human proteome and serve as
gatekeepers of cellular function, integrating external signal information into gene expression …

Transcriptional network dynamics in early T cell development

B Shin, SJ Chang, BW MacNabb… - Journal of Experimental …, 2024 - rupress.org
The rate at which cells enter the T cell pathway depends not only on the immigration of
hematopoietic precursors into the strong Notch signaling environment of the thymus but also …

JAK2V617F-mediated phosphorylation of PRMT5 downregulates its methyltransferase activity and promotes myeloproliferation

F Liu, X Zhao, F Perna, L Wang, P Koppikar… - Cancer cell, 2011 - cell.com
Summary The JAK2V617F constitutively activated tyrosine kinase is found in most patients
with myeloproliferative neoplasms. While examining the interaction between JAK2 and …